Based on the analysis of LeMaitre Vascular's profitability, liquidity, and operating efficiency, LeMaitre Vascular is performing exceptionally good at this time. It has a great probability to report excellent financial results in December. At this time, LeMaitre Vascular's Other Stockholder Equity is comparatively stable compared to the past year. Total Liabilities is likely to gain to about 51.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 17.3 M in 2024. Key indicators impacting LeMaitre Vascular's financial strength include:
The financial analysis of LeMaitre Vascular is a critical element in measuring its lifeblood. Investors should not minimize LeMaitre Vascular's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
31.61 Million
LeMaitre
Select Account or Indicator
Market Cap
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Other Cashflows From Investing Activities
Change To Account Receivables
Total Cashflows From Investing Activities
Dividends Paid
Change Receivables
Net Borrowings
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Change To Liabilities
Investments
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Debt
Non Current Assets Total
Non Currrent Assets Other
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Short Term Debt
Cash
Cash And Short Term Investments
Non Current Liabilities Total
Other Liab
Property Plant And Equipment Net
Current Deferred Revenue
Retained Earnings
Accounts Payable
Other Assets
Long Term Debt
Net Receivables
Good Will
Common Stock Total Equity
Short Term Investments
Inventory
Property Plant And Equipment Gross
Accumulated Other Comprehensive Income
Treasury Stock
Intangible Assets
Common Stock
Property Plant Equipment
Net Tangible Assets
Retained Earnings Total Equity
Capital Surpluse
Deferred Long Term Liab
Non Current Liabilities Other
Deferred Long Term Asset Charges
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Depreciation And Amortization
Selling General Administrative
Net Income Applicable To Common Shares
Selling And Marketing Expenses
Net Income From Continuing Ops
Non Recurring
Non Operating Income Net Other
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past LeMaitre Vascular Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of LeMaitre Vascular's financial statements are interrelated, with each one affecting the others. For example, an increase in LeMaitre Vascular's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in LeMaitre Vascular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LeMaitre Vascular. Check LeMaitre Vascular's Beneish M Score to see the likelihood of LeMaitre Vascular's management manipulating its earnings.
LeMaitre Vascular Stock Summary
LeMaitre Vascular competes with InfuSystems Holdings, Pro Dex, Utah Medical, Milestone Scientific, and Hologic. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people.
The reason investors look at the income statement is to determine what LeMaitre Vascular's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining LeMaitre Vascular's current stock value. Our valuation model uses many indicators to compare LeMaitre Vascular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LeMaitre Vascular competition to find correlations between indicators driving LeMaitre Vascular's intrinsic value. More Info.
LeMaitre Vascular is rated fifth overall in return on equity category among its peers. It is rated third overall in return on asset category among its peers reporting about 0.65 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for LeMaitre Vascular is roughly 1.53 . At this time, LeMaitre Vascular's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value LeMaitre Vascular by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
LeMaitre Vascular Systematic Risk
LeMaitre Vascular's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. LeMaitre Vascular volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on LeMaitre Vascular correlated with the market. If Beta is less than 0 LeMaitre Vascular generally moves in the opposite direction as compared to the market. If LeMaitre Vascular Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one LeMaitre Vascular is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of LeMaitre Vascular is generally in the same direction as the market. If Beta > 1 LeMaitre Vascular moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in LeMaitre Vascular Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LeMaitre Vascular's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of LeMaitre Vascular growth as a starting point in their analysis.
LeMaitre Vascular November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of LeMaitre Vascular help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LeMaitre Vascular. We use our internally-developed statistical techniques to arrive at the intrinsic value of LeMaitre Vascular based on widely used predictive technical indicators. In general, we focus on analyzing LeMaitre Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LeMaitre Vascular's daily price indicators and compare them against related drivers.
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.